J. Choe, M. Kelker, and I. Wilson, Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain, Science, vol.309, issue.5734, p.581, 2005.
DOI : 10.1126/science.1115253

R. Schauvliege, S. Janssens, and R. Beyaert, Pellino Proteins: Novel Players in TLR and IL-1R Signalling, Journal of Cellular and Molecular Medicine, vol.169, issue.3, p.453, 2007.
DOI : 10.1074/jbc.M400241200

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922352

M. Yamamoto, S. Sato, K. Mori, K. Hoshino, O. Takeuchi et al., Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-?? Promoter in the Toll-Like Receptor Signaling, The Journal of Immunology, vol.169, issue.12, p.6668, 2002.
DOI : 10.4049/jimmunol.169.12.6668

S. Miggin, O. Neill, and L. , New insights into the regulation of TLR signaling, Journal of Leukocyte Biology, vol.80, issue.2, p.220, 2006.
DOI : 10.1189/jlb.1105672

D. Rowe, A. Mcgettrick, E. Latz, B. Monks, N. Gay et al., The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction, Proceedings of the National Academy of Sciences, vol.103, issue.16, p.6299, 2006.
DOI : 10.1073/pnas.0510041103

N. Gay and M. Gangloff, Structure and Function of Toll Receptors and Their Ligands, Annual Review of Biochemistry, vol.76, issue.1, p.141, 2007.
DOI : 10.1146/annurev.biochem.76.060305.151318

C. Leifer, M. Kennedy, A. Mazzoni, C. Lee, M. Kruhlak et al., TLR9 Is Localized in the Endoplasmic Reticulum Prior to Stimulation, The Journal of Immunology, vol.173, issue.2, p.1179, 2004.
DOI : 10.4049/jimmunol.173.2.1179

B. Gantner, R. Simmons, S. Canavera, S. Akira, and D. Underhill, Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2, The Journal of Experimental Medicine, vol.63, issue.9, p.1107, 2003.
DOI : 10.1093/infdis/163.5.1154

E. Palsson-mcdermott, O. Neill, and L. , The potential of targeting Toll-like receptor??2 in autoimmune and inflammatory diseases, Irish Journal of Medical Science, vol.8, issue.4, p.253, 2007.
DOI : 10.1007/s11845-007-0103-1

G. Brown, J. Herre, D. Williams, J. Willment, A. Marshall et al., Dectin-1 Mediates the Biological Effects of ??-Glucans, The Journal of Experimental Medicine, vol.160, issue.9, p.1119, 2003.
DOI : 10.1016/0022-1759(94)90018-3

A. Poltorak, X. He, I. Smirnova, M. Liu, C. Van-huffel et al., Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene, Science, vol.282, issue.5396, p.2085, 1998.
DOI : 10.1126/science.282.5396.2085

A. Ashkar and K. Rosenthal, Toll-like Receptor 9, CpG DNA and Innate Immunity, Current Molecular Medicine, vol.2, issue.6, p.545, 2002.
DOI : 10.2174/1566524023362159

C. Stevigny, C. Bailly, and J. Quetin-leclercq, Cytotoxic and Antitumor Potentialities of Aporphinoid Alkaloids, Current Medicinal Chemistry-Anti-Cancer Agents, vol.5, issue.2, p.173, 2005.
DOI : 10.2174/1568011053174864

R. Kuo, F. Chang, C. Chen, C. Teng, H. Yen et al., Antiplatelet activity of N-methoxycarbonyl aporphines from Rollinia mucosa, Phytochemistry, vol.57, issue.3, p.421, 2001.
DOI : 10.1016/S0031-9422(01)00076-0

D. Bhakuni and S. Gupta, Alkaloids of Litsea wightiana, Planta Medica, vol.48, issue.05, p.52, 1983.
DOI : 10.1055/s-2007-969878

F. Orallo, F. Alzueta, A. Campos-toimil, M. Calleja, and J. , Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats, British Journal of Pharmacology, vol.296, issue.7, p.1419, 1995.
DOI : 10.1111/j.1476-5381.1995.tb13364.x

N. Ivanovska, S. Philipov, and P. Georgieva, IMMUNOPHARMACOLOGICAL ACTIVITY OF APORPHINOID ALKALOID OXOGLAUCINE, Pharmacological Research, vol.35, issue.4, p.267, 1997.
DOI : 10.1006/phrs.1996.9994

G. Theiner, S. Rossner, A. Dalpke, K. Bode, T. Berger et al., TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells, Molecular Immunology, vol.45, issue.1, p.244, 2008.
DOI : 10.1016/j.molimm.2007.02.021